July 1, 2026- Physicians are reporting new shortages of widely used generic cancer drugs, prompting fears that some treatments will need to be delayed or rationed, according to Axios. Shortages of several generic chemotherapy drugs, due to manufacturing problems, shipping delays and decisions by some companies to stop producing the medications have contributed to shortages of carboplatin, cisplatin, oxaliplatin and ifosfamide, according to a June 24 New York Times report. These drugs that form the backbone of treatment for breast, lung, head and neck, ovarian, testicular and bladder cancers.